Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 150 /hr

★★★★★

☆☆☆☆☆

Hire John R.

United States

USD 150 /hr

PhD Immunologist | CAR-T, CAR-NK, T-Cell Engagers | Preclinical & Translational Immunotherapy Expert

Profile Summary

I am a PhD-trained immunologist with 6+ years of industry experience leading preclinical and translational immunotherapy programs in oncology and autoimmunity. I have extensive hands-on and strategic expertise in CAR-T and CAR-NK development, T-cell engagers (BCMA/CD3, GPRC5D/CD3), and bispecific antibodies, advancing programs from discovery through IND-enabling development. I specialize in translating complex mechanistic data into actionable insights for internal teams, CROs, and external collaborators. My experience spans in vitro and in vivo modeling, including syngeneic, xenograft, and humanized mouse studies, autoimmune modeling, human immune cell profiling, and translational biomarker strategy. I have led cross-functional teams, guided preclinical study design, and supported portfolio prioritization, strategic investment decisions, and external collaborations. I am available for short-term consulting, advisory calls, and project-based engagements in immunotherapy development, preclinical strategy, and translational biomarker alignment.

Subject Matter Expertise

• ☆ Biochemistry
• ☆ Immunoassay
• ☆ Cell Biology
• ☆ Cell-Based Assays
• ☆ Cell Signaling Pathways
• ☆ Stem Cell Research
• ☆ Basic Immunology
• ☆ Adjuvant & Antigen Research
• ☆ Biotechnology & Bioengineering
• ☆ Recombinant Protein Expression
• ☆ Primary Cells
• ☆ Cell Line Engineering
• ☆ Biomolecular Engineering
• ☆ Genetic Engineering
• ☆ Gene Editing/CRISPR
• ☆ Antibody Engineering
• ☆ Gene Delivery
• ☆ Cytometry
• ☆ Allergy & Clinical Immunology
• ☆ Clinical Immunology

Services

• Research
• Consulting

Research Market Research, User Research, Meta-Research, Feasibility Study, Scientific and Technical Research

Consulting Operations Consulting, Scientific and Technical Consulting

Work Experience

Principal Scientist

Fate Therapeutics (United States)

May 2019 - August 2025

Education

PhD (Molecular Medicine - Cancer Biology)

University of Maryland, Baltimore

August 2013 - March 2019

BS (Biology)

Saint Michael's College

2009 - 2013

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Moles MW, Erdlei H, Menzel L, Massaro M, Fiori A, Bunse M, Schrimpf M, Gerlach K, Gudipati V, Reiser J, et al. (2024). CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma . Frontiers in immunology.

Reiser J, Sadashivaiah K, Furusawa A, Banerjee A, Singh N (2018). Eomesodermin driven IL-10 production in effector CD8+ T cells promotes a memory phenotype . Cellular immunology.

Furusawa A, Reiser J, Sadashivaiah K, Simpson H, Banerjee A (2018). Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy . Journal of immunotherapy (Hagerstown, Md. : 1997).

Reiser J, Banerjee A (2016). Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response . Journal of immunology research.